跳至主要内容
临床试验/NCT00921284
NCT00921284已完成3 期

Closed-Loop Delivery of Propofol and Remifentanil: Sparing Effect of Dexmedetomidine

Hopital Foch1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2009年6月最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
发起方
Hopital Foch
入组人数
66
试验地点
1
主要终点
administered doses of propofol and of remifentanil during anesthesia

研究概览

简要总结

The main objective if to evaluate the sparing effect of dexmedetomidine on the doses of propofol and remifentanil.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • male patients scheduled for a general anesthesia

排除标准

  • age lower than 18 years
  • allergy to propofol, or to soja or to peanuts, or to sufentanil, to remifentanil, or to morphine,or to a myorelaxant or to an excipient,
  • hypersensibility to sufentanil, or to remifentanil, or to other derivate of fentanyl,
  • history of central nervous system disease,
  • patients receiving a psychotropic treatment or an agonist-antagonist opiate,
  • hypovolemic patients,
  • patients receiving a cardio-vascular treatment,
  • expected bleeding surgical procedure,
  • simultaneous general and loco-regional anesthesia,
  • severe hepatic insufficiency.

研究组 & 干预措施

Placebo

Placebo Comparator

patients will receive a closed-loop administration of propofol and remifentanil according to bispectral level and a placebo

干预措施: NaCl 9/00 (Drug)

dexmedetomidine

Experimental

patients will receive a closed-loop administration of propofol and remifentanil according to bispectral level and dexmedetomidine

干预措施: dexmedetomidine (Drug)

结局指标

主要结局

administered doses of propofol and of remifentanil during anesthesia

时间窗: end of anesthesia

次要结局

  • delay before recovery(at the end of anesthesia)
  • hemodynamic abnormalities requiring a treatment(end of anesthesia)
  • explicit memorisation(Second postoperative day)
  • postoperative morphine requirement(Third post-anesthetic hour)

研究者

发起方
Hopital Foch
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验